Benjamin B. Kasten

670 total citations
25 papers, 512 citations indexed

About

Benjamin B. Kasten is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Benjamin B. Kasten has authored 25 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Benjamin B. Kasten's work include Radiopharmaceutical Chemistry and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Peptidase Inhibition and Analysis (6 papers). Benjamin B. Kasten is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Peptidase Inhibition and Analysis (6 papers). Benjamin B. Kasten collaborates with scholars based in United States, China and Australia. Benjamin B. Kasten's co-authors include Paul D. Benny, Kurt R. Zinn, Soldano Ferrone, Donald J. Buchsbaum, Jinda Fan, Jason M. Warram, Clifford E. Berkman, Harrison Kim, Charles L. Barnes and Neha Udayakumar and has published in prestigious journals such as Chemical Communications, Annals of Surgery and Scientific Reports.

In The Last Decade

Benjamin B. Kasten

23 papers receiving 510 citations

Peers

Benjamin B. Kasten
Desirée L. Bos Netherlands
Summer Y.Y. Ha Hong Kong
Erasmus Poku United States
Chiara Da Pieve United Kingdom
Komal Mandleywala United States
Gilbert Green United States
Heling Zhou United States
Desirée L. Bos Netherlands
Benjamin B. Kasten
Citations per year, relative to Benjamin B. Kasten Benjamin B. Kasten (= 1×) peers Desirée L. Bos

Countries citing papers authored by Benjamin B. Kasten

Since Specialization
Citations

This map shows the geographic impact of Benjamin B. Kasten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin B. Kasten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin B. Kasten more than expected).

Fields of papers citing papers by Benjamin B. Kasten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin B. Kasten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin B. Kasten. The network helps show where Benjamin B. Kasten may publish in the future.

Co-authorship network of co-authors of Benjamin B. Kasten

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin B. Kasten. A scholar is included among the top collaborators of Benjamin B. Kasten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin B. Kasten. Benjamin B. Kasten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kasten, Benjamin B., Jack M. Rogers, Carlos Cárdenas, et al.. (2025). Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel Immunotherapies. Cancers. 17(19). 3176–3176. 1 indexed citations
2.
Kasten, Benjamin B., Tingting Dai, Ke Jiang, et al.. (2025). Comparison of 5-aminolevulinic acid and MMP-14 targeted peptide probes in preclinical models of GBM. Theranostics. 15(8). 3517–3531.
4.
Ovaitt, Alyssa K., Jason C. Fleming, Benjamin Greene, et al.. (2023). Determination of Flap Survival Isolated From Wound Bed Vasculature Using a Murine Axial Flap Model. Ear Nose & Throat Journal. 105(1). NP29–NP36. 1 indexed citations
5.
Kasten, Benjamin B., Hailey Houson, Jennifer Coleman, et al.. (2021). Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model. Scientific Reports. 11(1). 15384–15384. 19 indexed citations
6.
Kasten, Benjamin B., Ke Jiang, Aditi Jani, et al.. (2019). Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. 47(6). 1412–1426. 49 indexed citations
7.
Kasten, Benjamin B., Neha Udayakumar, Jianmei W. Leavenworth, et al.. (2019). Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology. Theranostics. 9(17). 5085–5104. 27 indexed citations
8.
Walsh, Erika M., Kiranya E. Tipirneni, Kirby I. Bland, et al.. (2019). Fluorescence Imaging of Nerves During Surgery. Annals of Surgery. 270(1). 69–76. 56 indexed citations
9.
Kasten, Benjamin B., Rebecca C. Arend, Ashwini A. Katre, et al.. (2017). B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models. Nuclear Medicine and Biology. 47. 23–30. 61 indexed citations
10.
Kasten, Benjamin B., Jinda Fan, Soldano Ferrone, et al.. (2017). 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models. Nuclear Medicine and Biology. 58. 67–73. 48 indexed citations
11.
Jani, Aditi, Melissa L. Korb, Kiranya E. Tipirneni, et al.. (2017). Characterizing the detection threshold for optical imaging in surgical oncology. Journal of Surgical Oncology. 116(7). 898–906. 13 indexed citations
12.
Kasten, Benjamin B., Michael Azure, Trenton R. Schoeb, Darrell R. Fisher, & Kurt R. Zinn. (2016). Imaging, biodistribution, and toxicology evaluation of 212Pb-TCMC-trastuzumab in nonhuman primates. Nuclear Medicine and Biology. 43(7). 391–396. 17 indexed citations
13.
Kasten, Benjamin B., Jinda Fan, Soldano Ferrone, Kurt R. Zinn, & Donald J. Buchsbaum. (2016). Targeted radioimmunotherapy of triple negative breast cancer with CSPG4-specific 212Pb-labeled monoclonal antibody.. 57. 114–114. 6 indexed citations
14.
Kasten, Benjamin B., Xiaowei Ma, Kai Cheng, et al.. (2015). Isothiocyanate-Functionalized Bifunctional Chelates and fac-[MI(CO)3]+ (M = Re, 99mTc) Complexes for Targeting uPAR in Prostate Cancer. Bioconjugate Chemistry. 27(1). 130–142. 9 indexed citations
15.
Hayes, Thomas R., Benjamin B. Kasten, Charles L. Barnes, & Paul D. Benny. (2014). Rhenium and technetium bi- and tricarbonyl complexes in a new strategy for biomolecule incorporation using click chemistry. Dalton Transactions. 43(19). 6998–7001. 21 indexed citations
16.
Kasten, Benjamin B., Paul D. Benny, Rory L. Arrowsmith, et al.. (2014). Re and99mTc complexes of BodP3– multi-modality imaging probes. Chemical Communications. 50(98). 15503–15505. 14 indexed citations
17.
Kasten, Benjamin B., et al.. (2014). Cu-Free 1,3-Dipolar Cycloaddition Click Reactions To Form Isoxazole Linkers in Chelating Ligands for fac-[MI(CO)3]+ Centers (M = Re, 99mTc). Inorganic Chemistry. 53(4). 1943–1945. 4 indexed citations
18.
Kasten, Benjamin B., Tiancheng Liu, Jessie R. Nedrow, Paul D. Benny, & Clifford E. Berkman. (2012). Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles. Bioorganic & Medicinal Chemistry Letters. 23(2). 565–568. 41 indexed citations
19.
Jiang, Han, Benjamin B. Kasten, Hongguang Liu, et al.. (2012). Novel, Cysteine-Modified Chelation Strategy for the Incorporation of [MI(CO)3]+ (M = Re, 99mTc) in an α-MSH Peptide. Bioconjugate Chemistry. 23(11). 2300–2312. 21 indexed citations
20.
Ganguly, Tanushree, Benjamin B. Kasten, Dejan-Krešimir Buč̌ar, et al.. (2011). The hydrazide/hydrazone click reaction as a biomolecule labeling strategy for M(CO)3 (M = Re, 99mTc) radiopharmaceuticals. Chemical Communications. 47(48). 12846–12846. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026